Descriptor English: | Arsenic Trioxide |
Descriptor Spanish: | Trióxido de Arsénico |
Descriptor Portuguese: | Trióxido de Arsênio |
Descriptor French: | Trioxyde d'arsenic |
Entry term(s): |
Arsenic Oxide (As2O3) Arsenic Oxide (As4O6) Arsenic(III) Oxide Arsenolite Arsenous Anhydride As2O3 As4O6 Diarsenic Trioxide Naonobin Tetra Arsenic Hexaoxide Tetra Arsenic Oxide Tetra-Arsenic Hexaoxide Tetra-Arsenic Oxide Tetraarsenic Hexaoxide Tetraarsenic Oxide Trisenox Trixenox |
Tree number(s): |
D01.075.038 D01.650.550.125 |
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077237 |
Scope note: | An inorganic compound with the chemical formula As2O3 that is used for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA in patients who have relapsed from, or are resistant to, conventional drug therapy. |
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
Pharm Action: |
Antineoplastic Agents |
Registry Number: | S7V92P67HO |
Public MeSH Note: | 2019; ARSENIC TRIOXIDE was indexed under ARSENICALS and OXIDES 1975-2018 |
History Note: | 2019 (1975) |
DeCS ID: | 57559 |
Unique ID: | D000077237 |
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents |
Date Established: | 2019/01/01 |
Date of Entry: | 2018/07/09 |
Revision Date: | 2018/02/27 |
-
-
CHEMICALS AND DRUGS
Inorganic Chemicals [D01]Inorganic Chemicals -
CHEMICALS AND DRUGS
Inorganic Chemicals [D01]Inorganic Chemicals
|
Arsenic Trioxide
- Preferred
Tetraarsenic Oxide
- Narrower
Naonobin
- Narrower
Trisenox
- Narrower
Concept UI |
M0049263 |
Scope note | An inorganic compound with the chemical formula As2O3 that is used for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA in patients who have relapsed from, or are resistant to, conventional drug therapy. |
Preferred term | Arsenic Trioxide |
Entry term(s) |
Arsenic Oxide (As2O3) Arsenic(III) Oxide Arsenous Anhydride As2O3 Diarsenic Trioxide |
Concept UI |
M0479370 |
Scope note | A form of As2O3 that exists as As4O6 in the solid state. It dissociates to As2O3 upon heating to the vapor phase above 800 degrees Celsius. |
Preferred term | Tetraarsenic Oxide |
Entry term(s) |
Arsenic Oxide (As4O6) Arsenolite As4O6 Tetra Arsenic Hexaoxide Tetra Arsenic Oxide Tetra-Arsenic Hexaoxide Tetra-Arsenic Oxide Tetraarsenic Hexaoxide |
Concept UI |
M0555701 |
Preferred term | Naonobin |
Concept UI |
M0398306 |
Preferred term | Trisenox |
Entry term(s) |
Trixenox |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey